VILLA, MATTEO
 Distribuzione geografica
Continente #
EU - Europa 710
NA - Nord America 403
AS - Asia 242
SA - Sud America 7
Totale 1.362
Nazione #
US - Stati Uniti d'America 397
IT - Italia 392
SG - Singapore 131
DE - Germania 88
IE - Irlanda 76
RU - Federazione Russa 43
HK - Hong Kong 39
ID - Indonesia 34
CN - Cina 28
FR - Francia 24
SE - Svezia 16
FI - Finlandia 15
GB - Regno Unito 14
NL - Olanda 10
AT - Austria 7
IN - India 7
PL - Polonia 6
BE - Belgio 5
PE - Perù 5
CA - Canada 4
LT - Lituania 3
BY - Bielorussia 2
DK - Danimarca 2
MK - Macedonia 2
TH - Thailandia 2
AR - Argentina 1
BG - Bulgaria 1
BR - Brasile 1
CH - Svizzera 1
CZ - Repubblica Ceca 1
KR - Corea 1
MX - Messico 1
PR - Porto Rico 1
RO - Romania 1
SK - Slovacchia (Repubblica Slovacca) 1
Totale 1.362
Città #
Milan 135
Singapore 108
Ann Arbor 96
Dublin 75
Frankfurt am Main 66
Hong Kong 38
New York 37
Jakarta 34
Chandler 33
Santa Clara 27
Fairfield 20
Ashburn 17
Rome 16
Carate Brianza 15
Monza 15
Desio 12
Helsinki 12
Beijing 10
Lissone 10
Munich 10
Shanghai 8
Cesano Maderno 7
Genoa 7
San Diego 7
Wilmington 7
Lodz 6
Princeton 6
Romola 6
Brussels 5
Houston 5
Lima 5
London 5
Los Angeles 5
Peschiera Borromeo 5
Sesto San Giovanni 5
Assago 4
Bergamo 4
Chicago 4
Corsico 4
Meaux 4
Vercelli 4
Ardea 3
Arese 3
Cinisello Balsamo 3
Lappeenranta 3
Lawrence 3
Marano di Napoli 3
Marino 3
Nuremberg 3
Osio Sotto 3
Portici 3
Vienna 3
Alexandria 2
Andover 2
Bangkok 2
Bari 2
Bhopal 2
Boardman 2
Bolzano 2
Bonndorf 2
Bradford 2
Cambridge 2
Ciserano 2
Corridonia 2
Créteil 2
Delhi 2
Ferrara 2
Garbagnate Milanese 2
Jinan 2
Legnano 2
Marseille 2
Monterotondo 2
Mountain View 2
Naples 2
Nerviano 2
Ottawa 2
Perugia 2
Pordenone 2
Rho 2
Romano d'Ezzelino 2
Salerno 2
San Severo 2
Seattle 2
Seregno 2
Seriate 2
Seveso 2
Sint Odilienberg 2
Southwark 2
Spresiano 2
Strumica 2
Trento 2
Vicenza 2
Villejuif 2
Washington 2
Woerden 2
Woodbridge 2
Yerres 2
Agrate Brianza 1
Amsterdam 1
Bobigny 1
Totale 1.025
Nome #
A Compound L1196M/G1202R ALK Mutation in a Patient with ALK-Positive Lung Cancer with Acquired Resistance to Brigatinib Also Confers Primary Resistance to Lorlatinib 259
Loss of CDKN2B expression as a potential marker of resistance to CDK4/6 inhibitor in Luminal Breast Cancer cells 199
Synergistic drug combinations prevent resistance in ALK+ anaplastic large cell lymphoma 132
DNA Damage Response (DDR) Is Associated With Treatment-free Remission in Chronic Myeloid Leukemia Patients 102
New pan-ALK inhibitor-resistant EML4::ALK mutations detected by liquid biopsy in lung cancer patients 98
TWIST1 Upregulation Is a Potential Target for Reversing Resistance to the CDK4/6 Inhibitor in Metastatic Luminal Breast Cancer Cells 90
New advances in liquid biopsy technologies for anaplastic lymphoma kinase (Alk)—positive cancer 87
Novel ALK mutations in EML4::ALK+ NSCLC resistant to TKIs identified by liquid biopsy 83
Evolutionary signatures of human cancers revealed via genomic analysis of over 35,000 patients 81
Characterization of cancer subtypes associated with clinical outcomes by multi-omics integrative clustering 72
Repurposing pexmetinib as an inhibitor of TKI-resistant BCR::ABL1 70
Effects of blocking CD24 and CD47 'don't eat me' signals in combination with rituximab in mantle-cell lymphoma and chronic lymphocytic leukaemia 64
Recurrent somatic mutations of FAT family cadherins induce an aggressive phenotype and poor prognosis in anaplastic large cell lymphoma 45
Synergistic drug combinations preventdrug resistance in anaplastic large cell lymphomapreclinical models 40
Anaplastic Lymphoma Kinase (ALK) Inhibitors Enhance Phagocytosis Induced by CD47 Blockade in Sensitive and Resistant ALK-Driven Malignancies 9
Totale 1.431
Categoria #
all - tutte 6.711
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 6.711


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/202047 0 0 0 0 0 0 9 11 10 9 8 0
2020/202196 5 1 13 7 11 12 13 10 8 4 6 6
2021/202269 5 6 4 4 10 5 8 3 7 6 3 8
2022/2023221 20 34 17 17 8 15 1 9 20 33 22 25
2023/2024477 41 22 22 20 59 94 73 16 34 23 30 43
2024/2025521 52 94 88 78 105 58 46 0 0 0 0 0
Totale 1.431